Research Article

Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients

Table 1

Clinical and laboratory characteristics of patients in DN group and control group.

ā€‰DN group ()Control group () value

Age (years)62.00 (54.00, 68.00)62.00 (55.00, 69.50)ns
Sex (male%)59.91 (257/429)55.05 (229/416)ns
BMI (kg/m2)26.25 (24.47, 28.55)25.40 (23.63, 27.73)ns
Duration of diabetes (years)15.00 (9.00, 20.00)13.00 (11.00, 18.00)ns
Systolic blood pressure (mmHg)138.00 (125.00, 150.00)130.00 (120.00, 140.00)ns
Diastolic blood pressure (mmHg)80.00 (73.25, 84.75)80.00 (73.50, 81.00)ns
Triglyceride (mmol/L)1.60 (1.28, 1.96)1.40 (0.85, 2.03)ns
Total cholesterol (mmol/L)4.00 (3.29, 5.13)3.99 (3.42, 4.67)ns
HDL cholesterol (mmol/L)0.92 (0.77, 1.14)1.02 (0.87, 1.21)ns
LDL cholesterol (mmol/L)2.21 (1.74, 2.93)2.25 (1.82, 2.86)ns
HbA1c (%)7.95 (6.50, 9.63)10.95 (8.08, 17.00)<0.05
Creatinine (mmol/L)107.30 (76.15, 187.45)63.30 (52.95, 75.50)<0.05
Creatinine clearance (ml/min/1.73ā€‰m2)85.50 (58.85, 120.26)112.80 (93.06, 140.22)<0.05
Urinary albumin (mg/day)330.62 (226.33, 438.92)13.70 (5.71, 28.17)<0.05